21 research outputs found
Large volume leukapheresis: efficacy and safety of processing patient's total blood volume six times
Get PDFLarge-volume leukapheresis (LVL) differs from standard leukapheresis by increased blood flow and an altered anticoagulation regimen. An open issue is to what degree a further increase in processed blood volume is reasonable in terms of higher yields and safety. In 30 LVL performed in patients with hematologic malignancies, 6 total blood volumes were processed. LVL resulted in a higher CD34+ cell yield without a change in graft quality. Although a marked platelet decrease can be expected, LVL is safe and can be recommended as the standard procedure for patients who mobilize low numbers of CD34+ cells and when high number of CD34+ cells are required
Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device
No full textDetermining factors predictive of CD34+ cell collection efficiency in an effort to avoid extended and repeated apheresis sessions
No full textMidpoint CD34 measurement as a predictor of PBPC product yield in pediatric patients undergoing high-dose chemotherapy
No full textKinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra-apheresis
No full textHematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator
No full textHPC-A dose prediction on the optia® cell separator based on a benchmark CE2 collection efficiency: Promoting clinical efficiency, minimizing toxicity, and allowing quality control
No full textMobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial
No full text
Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients
No full text
